Pacira BioSciences
PCRX
PCRX
196 hedge funds and large institutions have $1.97B invested in Pacira BioSciences in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 54 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 192 → 196 (+4)
5% more capital invested
Capital invested by funds: $1.87B → $1.97B (+$93M)
6.75% less ownership
Funds ownership: 109.53% → 102.79% (-6.7%)
Holders
196
Holding in Top 10
5
Calls
$23.1M
Puts
$18.5M
Top Buyers
| 1 | +$33.1M | |
| 2 | +$28.3M | |
| 3 | +$19.5M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$14.3M |
| 5 |
CHP
Castle Hook Partners
New York
|
+$14.1M |
Top Sellers
| 1 | -$44.3M | |
| 2 | -$30.3M | |
| 3 | -$28M | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$23.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$21.5M |